Skip to main content
. Author manuscript; available in PMC: 2021 Feb 24.
Published in final edited form as: Anal Biochem. 2017 Dec 7;543:97–107. doi: 10.1016/j.ab.2017.12.007

Table 1. Samples from individuals without and with Bacillus anthracis infection analyzed for lethal factor by MS.

Archived non-anthrax samples from the Meningitis and Special Pathogens Branch at CDC for cross validation which included: *Legionnaires’ Disease (n = 13), Chlamydophila pneumoniae (n = 9), Staphylococcus aureus (n = 3), influenza (n = 1), children from San Diego without vaccinations (n = 5), elderly individuals from Argentina (n = 5).

Source (species) Specimen Type Background/Exposure Number LF Result
A. Specificity
Human Serum Normal/North American 183 183 neg
Human Plasma Normal/North American 160 160 neg
Human Serum Other Infections* 40 40 neg
NZW Rabbits Plasma Pre-exposure (day 0) 31 31 neg
Rhesus macaques Serum/plasma Pre-exposure day −30, −40 24 24 neg
Total Individuals 438 438
B. Sensitivity
Human Serum/Plasma Inhalation 3 3 pos
Human Serum Cutaneous 18 18 pos
Human Serum/Plasma Gastrointestinal 1 1 pos
Human Serum/Plasma Injection 12 12 pos
NZW Rabbits Plasma Inhalation post-exposure 29 29 pos
Rhesus macaques Serum/plasma Inhalation post-exposure 24 24 pos
Total Individuals 87 87

Neg = negative for LF or < LOD, pos = positive result for LF.